Bayer poaches newest early R&D head from Roche; GlaxoSmithKline earns expanded nod for Shingrix

Bayer has plucked its new head of research and early development from Roche’s pRED organization, where he was doing much the same thing before making the leap.

The German pharma company announced this morning that it had signed up Dominik Ruettinger for the post. Before Roche,...

Click to view original post